Two designer drugs hit same lung cancer target, but only one is effective

... Study demonstrates presence or absence of gene mutation a critical factor in treatment choice - Two designer cancer drugs differed dramatically in a laboratory test comparing their ability to shut down a mutant, overactive growth signal in lung cancer cells, reports a team headed by scientists at the Dana-Farber Cancer Institute... click link for more info. ...